Spondyloarthritis & psoriatic arthritis
An international multicentre analysis of current prescribing practices and shared decision-making in psoriatic arthritis
Authors' conclusion
Our data indicate that in patients with mild disease activity, only those with higher perceived collaboration underwent treatment escalation.
Study context
- Population
- PsA patients ≥18 years attending face-to-face appointments, July 2021–March 2022, 24 centres in UK, France, Germany, Italy and Spain
- Participants
- 503 patients24 centres
- Exposure
- UK vs continental Europe
- Outcome
- Current prescribing practices and extent of shared decision-making (SDM) (CollaboRATE; PEPPI-5)
Methodological detailsobservational, multicentre, international
- Observational
- Multicentre
- International
Main finding
As reported in the abstract
Current PsA treatment
csDMARD
bDMARD
Observational data: associations, not effects.
Further findings
Treatment escalation in patients with low PsAID-12 scores (<5), by CollaboRATE score
- Low CollaboRATE (<4.5; n=31): patients with low PsAID-12 escalated
- 0
- CollaboRATE ≥4.5 (n=465): patients with low PsAID-12 escalated
- 59
Original publication
An international multicentre analysis of current prescribing practices and shared decision-making in psoriatic arthritis. Rheumatology (Oxford). Published 27 November 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →